# GE HealthCare

Source: https://nuclide.cc/companies/ge-healthcare/  
Nuclide record `ge-healthcare` (Company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

GE HealthCare, of Chicago, makes PET/CT, MRI and CT scanners (Omni Legend, SIGNA, Revolution) and PET tracers through its Pharmaceutical Diagnostics business, including Cerianna, the fluoroestradiol F-18 agent that images oestrogen receptors in breast cancer. Whether receptor-imaging tracers change treatment decisions often enough to be reimbursed is its tracer business's open question.

## Summary

GE HealthCare, based in Chicago and listed as GEHC, makes PET/CT, MRI and CT scanners and PET tracers through its Pharmaceutical Diagnostics business. Its scanners include the Omni Legend PET/CT, SIGNA MRI and Revolution CT, and its tracer business spans flurpiridaz, cyclotrons and Cerianna, the fluoroestradiol F-18 agent for imaging oestrogen receptor expression in breast cancer. Nuclide links it to PET/CT, MRI and CT, to medical cyclotrons and total-body PET hardware, and to the fluoroestradiol F-18 drug record. Whether receptor-imaging tracers such as FES change treatment decisions often enough to be reimbursed widely is the open question for its tracer business. Fluoroestradiol F-18 has its own page.

## Fields

- Kind: Company
- Last checked: 2026-09-04
- HQ: Chicago, IL
- Type: imaging
- Website: https://www.gehealthcare.com
- Ticker: GEHC

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/GE_HealthCare
- Official website: https://www.gehealthcare.com

## Connected records

- isotopes: [Fluorine-18](https://nuclide.cc/isotopes/f-18/), [Technetium-99m](https://nuclide.cc/isotopes/tc-99m/)
- technologies: [CT (computed tomography)](https://nuclide.cc/technologies/ct/), [CT, MRI and PET scanner manufacturing](https://nuclide.cc/technologies/medical-imaging-scanner-manufacturing/), [Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211)](https://nuclide.cc/technologies/cyclotron-isotope-production/), [FES PET (oestrogen receptor imaging)](https://nuclide.cc/technologies/fes-pet/), [Medical cyclotrons, hot cells, and synthesis modules](https://nuclide.cc/technologies/medical-cyclotrons-synthesis-modules/), [Nuclear medicine and total-body PET hardware](https://nuclide.cc/technologies/nuclear-medicine-hardware/), [PET/CT](https://nuclide.cc/technologies/pet-ct/), [PET/MRI](https://nuclide.cc/technologies/pet-mri/), [SPECT & bone scan](https://nuclide.cc/technologies/spect/), [SPECT/CT](https://nuclide.cc/technologies/spect-ct/)
- trials: [Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, o](https://nuclide.cc/trials/nct07219238/)
- drugs: [Fluoroestradiol F-18 (FES PET)](https://nuclide.cc/drugs/fluoroestradiol-f18/), [Flurpiridaz F-18](https://nuclide.cc/drugs/f-18-flurpiridaz/), [Flutemetamol F-18](https://nuclide.cc/drugs/f-18-flutemetamol/), [Gallium-68 FAPI-46](https://nuclide.cc/drugs/ga-68-fapi-46/), [Iobenguane I-123](https://nuclide.cc/drugs/i-123-mibg/), [Ioflupane I-123](https://nuclide.cc/drugs/i-123-ioflupane/), [Sodium fluoride F-18](https://nuclide.cc/drugs/f-18-naf/), [Technetium Tc-99m medronate (MDP)](https://nuclide.cc/drugs/tc-99m-mdp/), [Technetium-99m exametazime (brain perfusion)](https://nuclide.cc/drugs/tc-99m-hmpao-brain/)
- companies: [Nihon Medi-Physics](https://nuclide.cc/companies/nihon-medi-physics/)
- fronts: [Cardiac imaging](https://nuclide.cc/fronts/f-cardiac-imaging/), [Molecular imaging](https://nuclide.cc/fronts/f-molecular-imaging/), [Neuro-imaging](https://nuclide.cc/fronts/f-neuro-imaging/)

---
JSON: https://nuclide.cc/api/v1/entities/ge-healthcare.json